Dr. Florentina Lupascu | polymer nanoparticles | Best Paper Award
University of Medicine and Pharmacy Grigore T Popa Iasi , Romania.
Florentina Geanina Lupașcu is a dedicated Lecturer PhD in Pharmaceutical Chemistry at the University of Medicine and Pharmacy “Grigore T. Popa” Iași, Romania
. With expertise in pharmaceutical sciences, she has led innovative research in drug delivery systems, especially using polymers and nanoparticles
. A passionate mentor, she has coordinated numerous student theses and contributed extensively to the academic community through international collaborations
, impactful publications
, and scientific events. Her work has been recognized with prestigious awards
and editorial roles, showcasing her commitment to pharmaceutical advancement and professional excellence
.
PROFILE
Summary of Suitability:
Dr. Lupașcu has consistently contributed to the field of pharmaceutical sciences through original, high-impact research. Her publications include 37 full articles, 24 in ISI journals, and multiple authored books . She has led a key project on pioglitazone-curcumin-loaded chitosan nanoparticles, a novel drug delivery system targeting Type 2 diabetes mellitus – an area of urgent global healthcare need
. Her H-index (up to 11) and over 500 citations across platforms demonstrate significant scholarly influence
.
Education & Experience
Education:
-
Bachelor of Pharmacy, UMF “Grigore T. Popa” Iași (2004–2009)
-
PhD in Pharmaceutical Chemistry, UMF “Grigore T. Popa” Iași (2009–2013)
-
Residency in Pharmaceutical Laboratory (2015–2019)
-
Residency in General Pharmacy (2020–2023)
Experience:
-
Assistant, UMF Iași – Faculty of Pharmacy (2013–2016)
-
Lecturer, Pharmaceutical Chemistry (2016–present)
-
Scientific Coordinator – 40 graduation theses
-
Guidance Committee – 3 PhD students
-
Specializations abroad:
-
University of Ghent
(2012)
-
FIT 4-NANO Workshop, Lisbon
(2023)
-
Professional Development 

Dr. Lupașcu is actively involved in enhancing her scientific and academic profile through international research networks , professional societies, and specialized workshops
. She is a steering committee member in the COST Action CA19140 – Focused Ion Technology for Nanomaterials
and contributes to the advancement of pharmaceutical chemistry via roles in scientific societies and editorial boards
. Her participation in national and international conferences, editorial projects (e.g., Polymers, Pharmaceutics journals)
, and training programs such as drug administration techniques in animal models
highlights her dynamic engagement with cutting-edge pharmaceutical research and innovation
.
Research Focus 

Dr. Lupașcu’s research centers around innovative drug delivery systems, particularly those targeting type 2 diabetes mellitus therapy using biopolymer-based nanoparticles like chitosan . She has explored the synergy between active pharmaceutical ingredients such as pioglitazone and curcumin, embedded within polymer matrices to enhance therapeutic effects
. Her interest lies in optimizing the pharmacological profile of oral antidiabetic agents via nanotechnological approaches
. Active in interdisciplinary and translational research, she merges pharmaceutical chemistry, materials science, and nanomedicine
. Her work contributes to developing smarter, safer, and more effective drug systems for chronic diseases
.
Awards and Honors 

-
Best Paper Award – International Conference on Chemistry in Nanosciences and Biomaterials Engineering (June 2022)
-
Best Oral Presentation – International Conference on Chemistry in Nanosciences and Biomaterials Engineering (June 2021)
-
Originality of Results Award – Romanian National Pharmacy Congress, 16th Edition (October 2016)
Publications & Citations 
-
An overview of biopolymeric electrospun nanofibers based on polysaccharides for wound healing management
2020
Cited by 160
-
Recent biomedical approaches for chitosan based materials as drug delivery nanocarriers
2021
Cited by 94
-
The synthesis and the biological evaluation of new thiazolidin-4-one derivatives containing a xanthine moiety
2013
Cited by 40
-
New theophylline derivatives with potential pharmacological activity
2010
Cited by 34
-
Synthesis and biological evaluation of the new 1,3-dimethylxanthine derivatives with thiazolidine-4-one scaffold
2017
Cited by 29
-
Development and characterization of novel films based on sulfonamide-chitosan derivatives for potential wound dressing
2015
Cited by 28
-
New ibuprofen derivatives with thiazolidine-4-one scaffold with improved pharmaco-toxicological profile
2021
Cited by 18
-
The influence of a new rutin derivative on homocysteine, cholesterol and total antioxidative status in experimental diabetes in rat
2013
Cited by 17
-
The influence of a new rutin derivative in an experimental model of induced hyperhomocysteinemia in rats
2017
Cited by 16
-
Synthesis and biological evaluation of some new rutin semisynthetic derivatives as antibacterial agents
2012
Cited by 11
-
New derivatives of aryl-propionic acid. Synthesis and biological evaluation
2013
Cited by 6
-
New hydrazones with pyrazolone structure: synthesis, characterization and biological evaluation
2013
Cited by 6
Conclusion:
Given her pioneering work in nanomedicine, consistent scientific productivity, and prior accolades, Dr. Florentina Lupașcu exemplifies the qualities of a Best Paper Award recipient. Her research offers both academic value and real-world therapeutic potential, making her a standout candidate for further recognition .